<DOC>
	<DOCNO>NCT02155517</DOCNO>
	<brief_summary>Actually , Schnider Cortinez model represent pharmacokinetics model propofol complete publish . Schnider derive 24 healhty people , include covariates addition weight , age , height lean body mass though . Schnider model use obese patient . Cortínez model derive 20 obese patient . The difference model found initial drug distribution , mean V1 constant Ke0 ( pharmacokinetics factor define plasma-effect equilibration time ) . We believe Cortinez model also could use No OBESE patient allometric model , one way evaluate compare pharmacokinetics model study temporary course effect . The main objective study evaluate BIS Cardiac Output value propofol-induced sedation use Schnider Cortinez model Target Controlled infusion non obese healthy volunteer .</brief_summary>
	<brief_title>Clinical Effect Two Pharmacokinetics Model Propofol</brief_title>
	<detailed_description>The study approve ethic committee Avila Clinic . After informed consent , 10 volunteer age 18-60 años , ASA I , Body mass Index &lt; 30 include . The patient fast 8h protocol receive premedication . After arrival operating room , insertion 18-gauge intravenous cannula place forearm , Ringer 's lactate solution initiate . Oxygen therapy rate 5 litre per minute administer spontaneous ventilation . In case hypoventilation ( saturation ( SaO2 ) &lt; 95 % manual ventilation mask 10 l/min O2 administer . All volunteer monitoring EKG , Blood pressure , Pulse Oximetry , Bispectral Index Cardiac output . Propofol administer use commercially available target-controlled infusion incorporate pharmacokinetic model develop Schnider Cortinez ( arcomed ag , Medical System , Switzerland ) . Each volunteer study twice , mean subject act control . The study make two stage : STAGE I : All volunteer receive propofol infusion first model randomly choose ( Schnider Cortinez ) use Target Controlled Infusion device , initial effect-site target concentration propofol 3 ug/ml 20 minute . STAGE II : 72 hour stage I . All volunteer receive propofol infusion first model randomly choose ( Schnider Cortinez ) use Target Controlled Infusion device , initial effect-site target concentration propofol 3 ug/ml 20 minute . Lost consciousness evaluate independent observer use two different criterion : OAA/S score &lt; 2 ( OAA/S2 ) correspond absence response moderate prodding loss eyelash reflex ( LOER ) . Time OAA/S2 time LOER measure well correspond brain plasma concentration propofol . At time , BIS Cardiac output value record . After 20 minute , infusion stop . Recovery consciousness ( ROC ) , assess every 10 patient wake , value Ce , BIS Cardiac Output . The electroencephalogram ( EEG ) activity monitor BIS Quatro platform® electrode BIS VISTA™ 1.01 monitor Vista bispectral index ( Covidien , USA ) . The information record every 20 second The cardiac output measure use Monitor ICON ® Electrical Cardiometric ™ Arterial blood pressure , heart rate , SaO2 , respiratory frequency measure start propofol infusion every 3 minute end trial . A decrease systolic arterial pressure ≥30 % basal value consider hypotension , heart rate &lt; 45 defined bradycardia . STATISTICAL ANALYSIS This prospective , descriptive comparative study . We use Wilcoxon-Mann-Whitney nonparametric test apply two independent sample</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<criteria>ASA physical status I Aged 1860 year Patients Body mass Index &lt; 30 . Patients Body mass Index &gt; 30 . Patients present psychiatric neurological disorder , endocrinemetabolical problem , respiratory cardiac disease , allergy problem . Patients pregnant breastfeeding . Patients treat psychotropic drug , include alcohol , 48 hour prior . Patients previous history anesthetic complication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>TCI , Schnider Model , Cortinez Model , BIS , Cardiac Output .</keyword>
</DOC>